OpenAI debuts GPT-Rosalind, a new limited access model for life sciences, and broader Codex plugin on Github

The journey from a laboratory hypothesis to a pharmacy shelf is one of the most grueling marathons in modern industry, typically spanning 10 to 15 years and billions of dollars in investment. Progress is often stymied not just by the inherent mysteries of biology, but by the "fragmented and difficult to scale" workflows that force researchers to manually pivot between the actual experimental design equipment, software, and databases.But OpenAI is releasing a new specialized model GPT-R...